| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
23,755 |
14,942 |
$2.64M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
8,482 |
5,654 |
$211K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
21,196 |
13,995 |
$199K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,168 |
1,144 |
$24K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,366 |
1,533 |
$18K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
563 |
413 |
$13K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
4,272 |
3,064 |
$12K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
3,319 |
2,328 |
$10K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
712 |
534 |
$9K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
753 |
603 |
$7K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
644 |
470 |
$5K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
687 |
431 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
12 |
12 |
$618.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,020 |
570 |
$615.96 |
| 87807 |
|
49 |
43 |
$557.19 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
619 |
410 |
$537.50 |
| 90682 |
|
20 |
17 |
$509.41 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,488 |
943 |
$456.17 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
562 |
371 |
$345.96 |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
225 |
139 |
$318.25 |
| 81003 |
|
670 |
373 |
$169.17 |
| 92551 |
|
27 |
26 |
$125.00 |
| 99173 |
|
83 |
65 |
$107.84 |
| 90686 |
|
100 |
82 |
$76.12 |
| 90647 |
|
135 |
85 |
$62.54 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
160 |
94 |
$48.07 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
19 |
13 |
$35.56 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
26 |
14 |
$3.18 |
| 90651 |
|
376 |
270 |
$0.11 |
| 90633 |
|
676 |
561 |
$0.11 |
| 87428 |
|
840 |
515 |
$0.00 |
| 90697 |
|
181 |
155 |
$0.00 |
| 90696 |
|
29 |
25 |
$0.00 |
| 90634 |
|
17 |
12 |
$0.00 |
| 90723 |
|
169 |
97 |
$0.00 |
| 90620 |
|
67 |
56 |
$0.00 |
| 82962 |
|
36 |
29 |
$0.00 |
| G2025 |
Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only |
39 |
16 |
$0.00 |
| 85018 |
|
46 |
14 |
$0.00 |
| 90474 |
|
13 |
12 |
$0.00 |
| 90670 |
|
821 |
560 |
$0.00 |
| 87634 |
|
211 |
129 |
$0.00 |
| 90715 |
|
218 |
169 |
$0.00 |
| 90710 |
|
288 |
228 |
$0.00 |
| 81025 |
|
72 |
53 |
$0.00 |
| 90734 |
|
497 |
354 |
$0.00 |
| 90681 |
|
13 |
12 |
$0.00 |